Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China · Delayed Price · Currency is CNY 8.50
-0.14 (-1.62%)
Feb 3, 2026, 3:00 PM CST
SHA:603567 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -332.62 | 438.22 | 472.74 | 185.44 | 332.1 | 436.29 |
Depreciation & Amortization | 158.88 | 158.88 | 190.44 | 169 | 137.1 | 155.89 |
Other Amortization | 13.07 | 13.07 | 10.75 | 12.18 | 17.78 | 21.64 |
Loss (Gain) From Sale of Assets | 1.68 | 1.68 | 0.26 | -39.52 | 0.89 | 0.11 |
Asset Writedown & Restructuring Costs | 0.63 | 0.63 | 3.91 | 1.47 | 0.3 | 0.11 |
Loss (Gain) From Sale of Investments | 9.69 | 9.69 | -464.47 | -24.73 | -242.67 | -20.32 |
Provision & Write-off of Bad Debts | 117.82 | 117.82 | 3.84 | -29.8 | 44.34 | 35.38 |
Other Operating Activities | 1,358 | 191.94 | 233.95 | 162.63 | 211.71 | 155.78 |
Change in Accounts Receivable | 304.34 | 304.34 | -891.41 | 107.18 | -1,233 | -548.8 |
Change in Inventory | -850.83 | -850.83 | 282.66 | -270.89 | 381.02 | -217.01 |
Change in Accounts Payable | -214.5 | -214.5 | -277.49 | -521.86 | -74.84 | 170.89 |
Change in Other Net Operating Assets | - | - | - | 0.62 | -0.87 | - |
Operating Cash Flow | 559.48 | 164.31 | -478.24 | -326.79 | -433.94 | 155.18 |
Operating Cash Flow Growth | - | - | - | - | - | -29.76% |
Capital Expenditures | -186.75 | -189.15 | -95.14 | -404.27 | -448.63 | -868.65 |
Sale of Property, Plant & Equipment | 118.59 | 118.2 | 129.45 | 0.64 | 3.7 | 0.87 |
Cash Acquisitions | - | - | - | -17.51 | - | - |
Divestitures | -122 | 0 | 94.87 | 369.74 | 373 | 50 |
Investment in Securities | -527.33 | -48.86 | -53 | 222.9 | -757.24 | -636.85 |
Other Investing Activities | 0.04 | 13.79 | 100.25 | 112.44 | 407.91 | 3.74 |
Investing Cash Flow | -717.46 | -106.02 | 176.43 | 283.93 | -421.26 | -1,451 |
Long-Term Debt Issued | - | 1,790 | 2,655 | 1,680 | 860 | 2,140 |
Total Debt Issued | 1,925 | 1,790 | 2,655 | 1,680 | 860 | 2,140 |
Long-Term Debt Repaid | - | -1,880 | -2,441 | -1,724 | -1,138 | -1,618 |
Total Debt Repaid | -2,234 | -1,880 | -2,441 | -1,724 | -1,138 | -1,618 |
Net Debt Issued (Repaid) | -308.93 | -90.19 | 214.05 | -44.4 | -278.12 | 522.11 |
Issuance of Common Stock | - | - | 219.68 | - | 1,228 | 101 |
Repurchase of Common Stock | - | - | - | -29.99 | - | - |
Common Dividends Paid | -277.46 | -324.28 | -158.28 | -243.55 | -143.73 | -332.22 |
Other Financing Activities | 3.92 | -39.7 | 490.24 | -101 | -8.7 | 1.21 |
Financing Cash Flow | -582.47 | -454.16 | 765.69 | -418.94 | 797.46 | 292.11 |
Net Cash Flow | -740.45 | -395.88 | 463.87 | -461.81 | -57.74 | -1,004 |
Free Cash Flow | 372.73 | -24.84 | -573.38 | -731.07 | -882.57 | -713.47 |
Free Cash Flow Margin | 23.37% | -0.92% | -18.27% | -17.35% | -21.39% | -20.96% |
Free Cash Flow Per Share | 0.40 | -0.03 | -0.61 | -0.78 | -1.02 | -0.84 |
Cash Income Tax Paid | 133.78 | 316.2 | 380.65 | 201.36 | 429.61 | 436.47 |
Levered Free Cash Flow | 341.71 | -272.95 | -746.75 | -404.69 | -881.7 | -1,337 |
Unlevered Free Cash Flow | 434.02 | -187.27 | -662.12 | -318.01 | -791.21 | -1,244 |
Change in Working Capital | -767.62 | -767.62 | -929.67 | -763.46 | -935.49 | -629.7 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.